Addus HomeCare (ADUS) Competitors

Addus HomeCare (NASDAQ:ADUS) and Amedisys (NASDAQ:AMED) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, community ranking, media sentiment, analyst recommendations, dividends and profitability.

Which has better earnings & valuation, ADUS or AMED?

Addus HomeCare has higher earnings, but lower revenue than Amedisys. Addus HomeCare is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.06B	2.05	$62.52M	$4.37	27.41
Amedisys	$2.24B	1.32	-$9.75M	$2.52	35.73

Is ADUS or AMED more profitable?

Addus HomeCare has a net margin of 6.50% compared to Amedisys' net margin of 3.57%. Amedisys' return on equity of 12.20% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.50%	9.62%	7.37%
Amedisys	3.57%	12.20%	6.74%

Which has more risk and volatility, ADUS or AMED?

Addus HomeCare has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

Does the media prefer ADUS or AMED?

In the previous week, Amedisys had 12 more articles in the media than Addus HomeCare. MarketBeat recorded 20 mentions for Amedisys and 8 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.10 beat Amedisys' score of -0.09 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amedisys	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	8 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts rate ADUS or AMED?

Addus HomeCare currently has a consensus price target of $131.63, indicating a potential upside of 9.89%. Amedisys has a consensus price target of $100.67, indicating a potential upside of 11.79%. Given Amedisys' higher possible upside, analysts clearly believe Amedisys is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89
Amedisys	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Does the MarketBeat Community prefer ADUS or AMED?

Amedisys received 175 more outperform votes than Addus HomeCare when rated by MarketBeat users. However, 68.67% of users gave Addus HomeCare an outperform vote while only 58.72% of users gave Amedisys an outperform vote.

Company	Underperform	Outperform
Addus HomeCare	Outperform Votes 320 68.67%	Underperform Votes 146 31.33%
Amedisys	Outperform Votes 495 58.72%	Underperform Votes 348 41.28%

Do institutionals & insiders have more ownership in ADUS or AMED?

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 94.4% of Amedisys shares are owned by institutional investors. 4.6% of Addus HomeCare shares are owned by insiders. Comparatively, 1.8% of Amedisys shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Addus HomeCare beats Amedisys on 13 of the 19 factors compared between the two stocks.